• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病患者血清和脑脊液中抗原结合β-淀粉样蛋白自身抗体水平升高。

Increased levels of antigen-bound β-amyloid autoantibodies in serum and cerebrospinal fluid of Alzheimer's disease patients.

机构信息

Laboratory of Analytical Chemistry and Biopolymer Structure Analysis, Department of Chemistry, University of Konstanz, Konstanz, Germany.

出版信息

PLoS One. 2013 Jul 18;8(7):e68996. doi: 10.1371/journal.pone.0068996. Print 2013.

DOI:10.1371/journal.pone.0068996
PMID:23874844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3715516/
Abstract

Recent studies have suggested a protective role of physiological β-amyloid autoantibodies (Aβ-autoantibodies) in Alzheimer's disease (AD). However, the determination of both free and dissociated Aβ-autoantibodies in serum hitherto has yielded inconsistent results regarding their function and possible biomarker value. Here we report the application of a new sandwich enzyme-linked immunosorbent assay (ELISA) for the determination of antigen-bound Aβ-autoantibodies (intact Aβ-IgG immune complexes) in serum and cerebrospinal fluid (CSF) of a total number of 112 AD patients and age- and gender-matched control subjects. Both serum and CSF levels of Aβ-IgG immune complexes were found to be significantly higher in AD patients compared to control subjects. Moreover, the levels of Aβ-IgG complexes were negatively correlated with the cognitive status across the groups, increasing with declining cognitive test performance of the subjects. Our results suggest a contribution of IgG-type autoantibodies to Aβ clearance in vivo and an increased immune response in AD, which may be associated with deficient Aβ-IgG removal. These findings may contribute to elucidating the role of Aβ-autoantibodies in AD pathophysiology and their potential application in AD diagnosis.

摘要

最近的研究表明,生理性β-淀粉样蛋白自身抗体(Aβ-自身抗体)在阿尔茨海默病(AD)中具有保护作用。然而,迄今为止,在血清中测定游离和游离的 Aβ-自身抗体,其功能和可能的生物标志物价值的结果并不一致。在这里,我们报告了一种新的夹心酶联免疫吸附测定(ELISA)在 112 名 AD 患者和年龄及性别匹配的对照组的血清和脑脊液(CSF)中测定结合抗原的 Aβ-自身抗体(完整的 Aβ-IgG 免疫复合物)的应用。与对照组相比,AD 患者的血清和 CSF 中 Aβ-IgG 免疫复合物水平均显著升高。此外,Aβ-IgG 复合物的水平与各组的认知状态呈负相关,随着受试者认知测试表现的下降而增加。我们的研究结果表明 IgG 型自身抗体对体内 Aβ 清除的贡献,以及 AD 中免疫反应的增加,这可能与 Aβ-IgG 清除不足有关。这些发现可能有助于阐明 Aβ-自身抗体在 AD 病理生理学中的作用及其在 AD 诊断中的潜在应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b889/3715516/39fedead6549/pone.0068996.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b889/3715516/4c80a6ab6765/pone.0068996.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b889/3715516/d969174b32f2/pone.0068996.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b889/3715516/69dedaa7d936/pone.0068996.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b889/3715516/b0079affd441/pone.0068996.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b889/3715516/39fedead6549/pone.0068996.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b889/3715516/4c80a6ab6765/pone.0068996.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b889/3715516/d969174b32f2/pone.0068996.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b889/3715516/69dedaa7d936/pone.0068996.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b889/3715516/b0079affd441/pone.0068996.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b889/3715516/39fedead6549/pone.0068996.g005.jpg

相似文献

1
Increased levels of antigen-bound β-amyloid autoantibodies in serum and cerebrospinal fluid of Alzheimer's disease patients.阿尔茨海默病患者血清和脑脊液中抗原结合β-淀粉样蛋白自身抗体水平升高。
PLoS One. 2013 Jul 18;8(7):e68996. doi: 10.1371/journal.pone.0068996. Print 2013.
2
Antigen-bound and free β-amyloid autoantibodies in serum of healthy adults.健康成年人血清中结合抗原和游离的β-淀粉样蛋白自身抗体。
PLoS One. 2012;7(9):e44516. doi: 10.1371/journal.pone.0044516. Epub 2012 Sep 4.
3
Blood and Cerebrospinal Fluid Autoantibody to Aβ Levels in Patients with Alzheimer's Disease: a Meta-Analysis Study.阿尔茨海默病患者血液和脑脊液中 Aβ 自身抗体水平的 Meta 分析研究。
J Mol Neurosci. 2020 Aug;70(8):1208-1215. doi: 10.1007/s12031-020-01528-5. Epub 2020 Mar 24.
4
Association between naturally occurring anti-amyloid β autoantibodies and medial temporal lobe atrophy in Alzheimer's disease.自然产生的抗淀粉样蛋白 β 自身抗体与阿尔茨海默病患者内侧颞叶萎缩的关系。
J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):126-131. doi: 10.1136/jnnp-2016-313476. Epub 2016 Jun 21.
5
Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias.路易体相关性痴呆患者的血清和脑脊液中抗淀粉样蛋白和神经胶质衍生抗原的自身抗体增加。
J Alzheimers Dis. 2011;26(1):171-9. doi: 10.3233/JAD-2011-110221.
6
Galanin and α-MSH autoantibodies in cerebrospinal fluid of patients with Alzheimer's disease.阿尔茨海默病患者脑脊液中的甘丙肽和 α-MSH 自身抗体。
J Neuroimmunol. 2011 Dec 15;240-241:114-20. doi: 10.1016/j.jneuroim.2011.10.003. Epub 2011 Nov 10.
7
Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development.阿尔茨海默病患者体内β-淀粉样肽(Aβ)自身抗体水平升高,且Aβ抗体可增强Aβ神经毒性:对疾病发病机制及疫苗研发的启示。
Neuromolecular Med. 2003;3(1):29-39. doi: 10.1385/nmm:3:1:29.
8
Increased Number of Plasma B Cells Producing Autoantibodies Against Aβ42 Protofibrils in Alzheimer's Disease.阿尔茨海默病中产生针对Aβ42原纤维自身抗体的血浆B细胞数量增加。
J Alzheimers Dis. 2015;48(1):63-72. doi: 10.3233/JAD-150236.
9
Autoimmune responses to amyloid structures of Abeta(25-35) peptide and human lysozyme in the serum of patients with progressive Alzheimer's disease.对进行性阿尔茨海默病患者血清中β淀粉样蛋白(25-35)肽和人溶菌酶淀粉样结构的自身免疫反应。
Dement Geriatr Cogn Disord. 2004;18(2):165-71. doi: 10.1159/000079197. Epub 2004 Jun 21.
10
Beta-amyloid auto-antibodies are reduced in Alzheimer's disease.β-淀粉样蛋白自身抗体在阿尔茨海默病中减少。
J Neuroimmunol. 2014 Sep 15;274(1-2):168-73. doi: 10.1016/j.jneuroim.2014.06.017. Epub 2014 Jun 27.

引用本文的文献

1
The role of autoantibodies in Alzheimer's disease: Pathogenetic connections or epiphenomena?自身抗体在阿尔茨海默病中的作用:致病关联还是附带现象?
Alzheimers Dement. 2025 Jul;21(7):e70484. doi: 10.1002/alz.70484.
2
Altered T-cell reactivity in the early stages of Alzheimer's disease.阿尔茨海默病早期阶段T细胞反应性的改变。
Brain. 2025 Sep 3;148(9):3364-3378. doi: 10.1093/brain/awaf167.
3
Autoantibody profiles in Alzheimer´s, Parkinson´s, and dementia with Lewy bodies: altered IgG affinity and IgG/IgM/IgA responses to alpha-synuclein, amyloid-beta, and tau in disease-specific pathological patterns.

本文引用的文献

1
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.淀粉样β沉积、神经退行性变与散发性阿尔茨海默病认知衰退:一项前瞻性队列研究。
Lancet Neurol. 2013 Apr;12(4):357-67. doi: 10.1016/S1474-4422(13)70044-9. Epub 2013 Mar 8.
2
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.阿尔茨海默病病理生理过程的追踪:动态生物标志物的更新假设模型。
Lancet Neurol. 2013 Feb;12(2):207-16. doi: 10.1016/S1474-4422(12)70291-0.
3
Antigen-bound and free β-amyloid autoantibodies in serum of healthy adults.
阿尔茨海默病、帕金森病和路易体痴呆中的自身抗体谱:在疾病特异性病理模式下,针对α-突触核蛋白、淀粉样β蛋白和tau蛋白的IgG亲和力改变以及IgG/IgM/IgA反应
J Neuroinflammation. 2024 Dec 3;21(1):317. doi: 10.1186/s12974-024-03293-3.
4
Neuroinflammation in Alzheimer's disease: insights from peripheral immune cells.阿尔茨海默病中的神经炎症:来自外周免疫细胞的见解
Immun Ageing. 2024 Jun 14;21(1):38. doi: 10.1186/s12979-024-00445-0.
5
Comparative methods for quantifying plasma biomarkers in Alzheimer's disease: Implications for the next frontier in cerebral amyloid angiopathy diagnostics.比较阿尔茨海默病患者血浆生物标志物定量的方法:对脑淀粉样血管病诊断下一个前沿的启示。
Alzheimers Dement. 2024 Feb;20(2):1436-1458. doi: 10.1002/alz.13510. Epub 2023 Oct 31.
6
Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond.炎症、自身免疫和神经退行性疾病、治疗学及其他。
Curr Neuropharmacol. 2024;22(6):1080-1109. doi: 10.2174/1570159X22666231017141636.
7
Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer's Disease.阿尔茨海默病发病机制的分子和细胞机制的研究进展。
Int J Mol Sci. 2023 Apr 14;24(8):7258. doi: 10.3390/ijms24087258.
8
Immune Regulatory Functions of Macrophages and Microglia in Central Nervous System Diseases.巨噬细胞和小神经胶质细胞在中枢神经系统疾病中的免疫调节功能。
Int J Mol Sci. 2023 Mar 21;24(6):5925. doi: 10.3390/ijms24065925.
9
Dysregulated Levels of Circulating Autoantibodies against Neuronal and Nervous System Autoantigens in COVID-19 Patients.新冠病毒感染患者中针对神经元和神经系统自身抗原的循环自身抗体水平失调
Diagnostics (Basel). 2023 Feb 12;13(4):687. doi: 10.3390/diagnostics13040687.
10
Acquired immunity and Alzheimer's disease.获得性免疫与阿尔茨海默病。
J Biomed Res. 2022 Jul 28;37(1):15-29. doi: 10.7555/JBR.36.20220083.
健康成年人血清中结合抗原和游离的β-淀粉样蛋白自身抗体。
PLoS One. 2012;7(9):e44516. doi: 10.1371/journal.pone.0044516. Epub 2012 Sep 4.
4
Genentech's Alzheimer's antibody trial to study disease prevention.基因泰克公司的阿尔茨海默病抗体试验旨在研究疾病预防。
Nat Biotechnol. 2012 Aug;30(8):731-2. doi: 10.1038/nbt0812-731.
5
Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease.载脂蛋白 E 及其受体:正常生物学功能及在阿尔茨海默病中的作用。
Cold Spring Harb Perspect Med. 2012 Mar;2(3):a006312. doi: 10.1101/cshperspect.a006312.
6
Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer's disease.评估先前提出的用于识别阿尔茨海默病的血浆生物标志物组合。
PLoS One. 2012;7(1):e29868. doi: 10.1371/journal.pone.0029868. Epub 2012 Jan 18.
7
ELISA measurement of specific non-antigen-bound antibodies to Aβ1-42 monomer and soluble oligomers in sera from Alzheimer's disease, mild cognitively impaired, and noncognitively impaired subjects.ELISA 法测定阿尔茨海默病、轻度认知障碍和认知正常受试者血清中特异性非抗原结合的 Aβ1-42 单体和可溶性寡聚物抗体。
J Neuroinflammation. 2011 Aug 9;8:93. doi: 10.1186/1742-2094-8-93.
8
Naturally occurring autoantibodies against beta-amyloid: investigating their role in transgenic animal and in vitro models of Alzheimer's disease.天然产生的针对β-淀粉样蛋白的自身抗体:研究其在阿尔茨海默病转基因动物和体外模型中的作用。
J Neurosci. 2011 Apr 13;31(15):5847-54. doi: 10.1523/JNEUROSCI.4401-10.2011.
9
pROC: an open-source package for R and S+ to analyze and compare ROC curves.pROC:一个用于 R 和 S+的开源软件包,用于分析和比较 ROC 曲线。
BMC Bioinformatics. 2011 Mar 17;12:77. doi: 10.1186/1471-2105-12-77.
10
Immunotherapy for Alzheimer's disease.阿尔茨海默病的免疫疗法。
J Intern Med. 2011 Jan;269(1):54-63. doi: 10.1111/j.1365-2796.2010.02315.x.